The Marine-Derived Triterpenoid Frondoside A Inhibits Thrombus Formation

Background: The marine-derived triterpenoid frondoside A inhibits the phosphatidylinositol-3-kinase (PI3K) pathway in cancer cells. Because this pathway is also crucially involved in platelet activation, we studied the effect of frondoside A on thrombus formation. Methods: Frondoside A effects on pl...

Full description

Bibliographic Details
Main Authors: Emmanuel Ampofo, Thomas Später, Lisa Nalbach, Michael D. Menger, Matthias W. Laschke
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/18/2/111
_version_ 1811278932939374592
author Emmanuel Ampofo
Thomas Später
Lisa Nalbach
Michael D. Menger
Matthias W. Laschke
author_facet Emmanuel Ampofo
Thomas Später
Lisa Nalbach
Michael D. Menger
Matthias W. Laschke
author_sort Emmanuel Ampofo
collection DOAJ
description Background: The marine-derived triterpenoid frondoside A inhibits the phosphatidylinositol-3-kinase (PI3K) pathway in cancer cells. Because this pathway is also crucially involved in platelet activation, we studied the effect of frondoside A on thrombus formation. Methods: Frondoside A effects on platelet viability, surface adhesion molecule expression, and intracellular signaling were analyzed by flow cytometry and Western blot. The effect of frondoside A was analyzed by photochemically induced thrombus formation in the mouse dorsal skinfold chamber model and by tail vein bleeding. Results: Concentrations of up to 15 µM frondoside A did not affect the viability of platelets, but reduced their surface expression of P-selectin (CD62P) and the activation of glycoprotein (GP)IIb/IIIa after agonist stimulation. Additional mechanistic analyses revealed that this was mediated by downregulation of PI3K-dependent Akt and extracellular-stimuli-responsive kinase (ERK) phosphorylation. Frondoside A significantly prolonged the complete vessel occlusion time in the mouse dorsal skinfold chamber model of photochemically induced thrombus formation and also the tail vein bleeding time when compared to vehicle-treated controls. Conclusion: Our findings demonstrated that frondoside A inhibits agonist-induced CD62P expression and activation of GPIIb/IIIa. Moreover, frondoside A suppresses thrombus formation. Therefore, this marine-derived triterpenoid may serve as a lead compound for the development of novel antithrombotic drugs.
first_indexed 2024-04-13T00:45:43Z
format Article
id doaj.art-a857090e697f47c092fe2064c6fc7c99
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-04-13T00:45:43Z
publishDate 2020-02-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-a857090e697f47c092fe2064c6fc7c992022-12-22T03:10:01ZengMDPI AGMarine Drugs1660-33972020-02-0118211110.3390/md18020111md18020111The Marine-Derived Triterpenoid Frondoside A Inhibits Thrombus FormationEmmanuel Ampofo0Thomas Später1Lisa Nalbach2Michael D. Menger3Matthias W. Laschke4Institute for Clinical & Experimental Surgery, Saarland University, 66421 Homburg/Saar, GermanyInstitute for Clinical & Experimental Surgery, Saarland University, 66421 Homburg/Saar, GermanyInstitute for Clinical & Experimental Surgery, Saarland University, 66421 Homburg/Saar, GermanyInstitute for Clinical & Experimental Surgery, Saarland University, 66421 Homburg/Saar, GermanyInstitute for Clinical & Experimental Surgery, Saarland University, 66421 Homburg/Saar, GermanyBackground: The marine-derived triterpenoid frondoside A inhibits the phosphatidylinositol-3-kinase (PI3K) pathway in cancer cells. Because this pathway is also crucially involved in platelet activation, we studied the effect of frondoside A on thrombus formation. Methods: Frondoside A effects on platelet viability, surface adhesion molecule expression, and intracellular signaling were analyzed by flow cytometry and Western blot. The effect of frondoside A was analyzed by photochemically induced thrombus formation in the mouse dorsal skinfold chamber model and by tail vein bleeding. Results: Concentrations of up to 15 µM frondoside A did not affect the viability of platelets, but reduced their surface expression of P-selectin (CD62P) and the activation of glycoprotein (GP)IIb/IIIa after agonist stimulation. Additional mechanistic analyses revealed that this was mediated by downregulation of PI3K-dependent Akt and extracellular-stimuli-responsive kinase (ERK) phosphorylation. Frondoside A significantly prolonged the complete vessel occlusion time in the mouse dorsal skinfold chamber model of photochemically induced thrombus formation and also the tail vein bleeding time when compared to vehicle-treated controls. Conclusion: Our findings demonstrated that frondoside A inhibits agonist-induced CD62P expression and activation of GPIIb/IIIa. Moreover, frondoside A suppresses thrombus formation. Therefore, this marine-derived triterpenoid may serve as a lead compound for the development of novel antithrombotic drugs.https://www.mdpi.com/1660-3397/18/2/111frondoside athrombus formationthrombosishemostasisplateletspi3kdorsal skinfold chamber
spellingShingle Emmanuel Ampofo
Thomas Später
Lisa Nalbach
Michael D. Menger
Matthias W. Laschke
The Marine-Derived Triterpenoid Frondoside A Inhibits Thrombus Formation
Marine Drugs
frondoside a
thrombus formation
thrombosis
hemostasis
platelets
pi3k
dorsal skinfold chamber
title The Marine-Derived Triterpenoid Frondoside A Inhibits Thrombus Formation
title_full The Marine-Derived Triterpenoid Frondoside A Inhibits Thrombus Formation
title_fullStr The Marine-Derived Triterpenoid Frondoside A Inhibits Thrombus Formation
title_full_unstemmed The Marine-Derived Triterpenoid Frondoside A Inhibits Thrombus Formation
title_short The Marine-Derived Triterpenoid Frondoside A Inhibits Thrombus Formation
title_sort marine derived triterpenoid frondoside a inhibits thrombus formation
topic frondoside a
thrombus formation
thrombosis
hemostasis
platelets
pi3k
dorsal skinfold chamber
url https://www.mdpi.com/1660-3397/18/2/111
work_keys_str_mv AT emmanuelampofo themarinederivedtriterpenoidfrondosideainhibitsthrombusformation
AT thomasspater themarinederivedtriterpenoidfrondosideainhibitsthrombusformation
AT lisanalbach themarinederivedtriterpenoidfrondosideainhibitsthrombusformation
AT michaeldmenger themarinederivedtriterpenoidfrondosideainhibitsthrombusformation
AT matthiaswlaschke themarinederivedtriterpenoidfrondosideainhibitsthrombusformation
AT emmanuelampofo marinederivedtriterpenoidfrondosideainhibitsthrombusformation
AT thomasspater marinederivedtriterpenoidfrondosideainhibitsthrombusformation
AT lisanalbach marinederivedtriterpenoidfrondosideainhibitsthrombusformation
AT michaeldmenger marinederivedtriterpenoidfrondosideainhibitsthrombusformation
AT matthiaswlaschke marinederivedtriterpenoidfrondosideainhibitsthrombusformation